Ciprofloxacin resistance and tolerance of Pseudomonas aeruginosa ocular isolates

Contact Lens and Anterior Eye - Tập 46 - Trang 101819 - 2023
Mahjabeen Khan1, Karen Ma1, Ingrid Wan1, Mark DP Willcox1
1School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales 2052, Australia

Tài liệu tham khảo

Meredith, 2015, Collective antibiotic tolerance: mechanisms, dynamics and intervention, Nat Chem Biol, 11, 182, 10.1038/nchembio.1754 Ezisi, 2018, Microbial keratitis – A review of epidemiology, pathogenesis, ocular manifestations, and management, Niger J Ophthalmol, 26, 13, 10.4103/njo.njo_2_18 Upadhyay, 2015, Diagnosing and managing microbial keratitis, Community Eye Health, 28, 3 Stapleton, 2020, Contact lens-related corneal infection in Australia, Clin Exp Optom, 103, 408, 10.1111/cxo.13082 Willcox, 2017, Contact lens –related keratitis and ocular microbiology: a review of the latest research related to the microbiota of the ocular surface, Contact Lens Spectrum, 32, 2 Keay, 2006, Microbial keratitis predisposing factors and morbidity, Ophthalmology, 113, 109, 10.1016/j.ophtha.2005.08.013 Willcox, 2012, Management and treatment of contact lens-related Pseudomonas keratitis, Clin Ophthalmol, 6, 919, 10.2147/OPTH.S25168 Austin, 2017, Empirical treatment of bacterial keratitis: an international survey of corneal specialists, BMJ Open Ophthalmol, 2, 10.1136/bmjophth-2016-000047 Green, 2008, Risk factors and causative organisms in microbial keratitis, Cornea, 27, 22, 10.1097/ICO.0b013e318156caf2 Gupta, 2015, In vitro antibiotic susceptibility of Pseudomonas aeruginosa corneal ulcer Isolates, Ocul Immunol Inflamm, 23, 252, 10.3109/09273948.2014.883545 Hsu, 2005, Fluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes, J Antimicrob Chemother, 55, 535, 10.1093/jac/dki026 Stower, 2020, Antibiotic tolerance leads to antibiotic resistance, Nat Med, 26, 163 Brauner, 2016, Distinguishing between resistance, tolerance and persistence to antibiotic treatment, Nat Rev Microbiol, 14, 320, 10.1038/nrmicro.2016.34 Kester, 2014, Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria, Crit Rev Biochem Mol Biol, 49, 91, 10.3109/10409238.2013.869543 Anderl, 2003, Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin, Antimicrob Agents Chemother, 47, 1251, 10.1128/AAC.47.4.1251-1256.2003 Finkel, 2006, Long-term survival during stationary phase: evolution and the GASP phenotype, Nat Rev Microbiol, 4, 113, 10.1038/nrmicro1340 Fridman, 2014, Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations, Nature, 513, 418, 10.1038/nature13469 Zhu, 2019, Universal antibiotic tolerance arising from antibiotic-triggered accumulation of pyocyanin in Pseudomonas aeruginosa, PLoS Biol, 17, e3000573, 10.1371/journal.pbio.3000573 Hall, 2017, Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria, FEMS Microbiol Rev, 41, 276, 10.1093/femsre/fux010 Spoering, 2001, Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials, J Bacteriol, 183, 6746, 10.1128/JB.183.23.6746-6751.2001 Hu, 2012, Nonmultiplying bacteria are profoundly tolerant to antibiotics, Handb Exp Pharmacol, 211, 99, 10.1007/978-3-642-28951-4_7 Walters, 2003, Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin, Antimicrob Agents Chemother, 47, 317, 10.1128/AAC.47.1.317-323.2003 Gefen, 2017, TDtest: easy detection of bacterial tolerance and persistence in clinical isolates by a modified disk-diffusion assay, Sci Rep, 7, 41284, 10.1038/srep41284 Khan, 2020, Susceptibility of Contact Lens-Related Pseudomonas aeruginosa Keratitis Isolates to Multipurpose Disinfecting Solutions, Disinfectants, and Antibiotics, Transl Vis Sci Technol, 9, 2, 10.1167/tvst.9.5.2 Weinstine, 2020 Breakpoint tables for interpretation of MICs and zone diameters. 10th ed.: European Committee on Antimicrobial Susceptibility Testing (EUCAST). 2020. Pasticci, 2011, Bactericidal activity of oxacillin and glycopeptides against Staphylococcus aureus in patients with endocarditis: looking for a relationship between tolerance and outcome, Ann Clin Microbiol Antimicrob, 10, 26, 10.1186/1476-0711-10-26 Kotkova, 2019, Evaluation of TD test for analysis of persistence or tolerance in clinical isolates of Staphylococcus aureus, J Microbiol Methods, 167, 10.1016/j.mimet.2019.105705 Cabrera-Aguas, 2022, Infectious keratitis: A review, Clin Exp Ophthalmol, 10.1111/ceo.14113 Tuomanen, 1986, Antibiotic tolerance among clinical isolates of bacteria, Antimicrob Agents Chemother, 30, 521, 10.1128/AAC.30.4.521 May, 1998, Glycopeptide tolerance in Staphylococcus aureus, J Antimicrob Chemother, 42, 189, 10.1093/jac/42.2.189 Azuma, 2020, Clinical significance of carbapenem-tolerant Pseudomonas aeruginosa isolated in the respiratory tract, Antibiotics (Basel), 9 Sherris, 1986, Problems in in vitro determination of antibiotic tolerance in clinical isolates, Antimicrob Agents Chemother, 30, 633, 10.1128/AAC.30.5.633 Pearce, 2022, The clinical treatment of bacterial keratitis: A review of drop instillation regimes, Cont Lens Anterior Eye, 101725 Su, 2010, The development of ciprofloxacin resistance in Pseudomonas aeruginosa involves multiple response stages and multiple proteins, Antimicrob Agents Chemother, 54, 4626, 10.1128/AAC.00762-10 Levin-Reisman, 2017, Antibiotic tolerance facilitates the evolution of resistance, Science, 355, 826, 10.1126/science.aaj2191 Khan, 2020, Antibiotic resistance characteristics of Pseudomonas aeruginosa isolated from keratitis in Australia and India, Antibiotics (Basel), 9 Budhiraja, 2021, Role of topical high concentration levofloxacin 1.5% in bacterial keratitis, Indian Journal of Ophthalmology Case Reports, 1, 643, 10.4103/ijo.IJO_3745_20 Acharya, 2020, Delhi Infectious Keratitis Study: Update on clinico-microbiological profile and outcomes of infectious keratitis, J Curr Ophthalmol, 32, 249, 10.4103/JOCO.JOCO_113_20